Down 19% YTD, Realty Income Stock Has Growth Potential
December 1st, 2020 by Trefis Team
Despite a 38% rise since the March 23 lows of this year, at the current price of around $60 per share we believe Realty Income stock (NYSE: O) has more to go. Realty Income, a REIT (Real Estate Investment Trust) with a portfolio of more than 65...
Despite Revenue Growth, F5 Networks Stock Can Drop by 15%
December 1st, 2020 by Trefis Team
F5 Networks stock (NASDAQ: FFIV) is up 16% since the beginning of this year, but at the current price of around $163 per share, we believe that F5 Networks stock has 15% potential downside. Why is that? Our belief stems from the fact that F5 N...
Freeport-McMoRan Stock Rises 4.5x – Time To Exit?
December 1st, 2020 by Trefis Team
After an eye-popping rise of more than 4.5x from its March lows of this year, at the current price of $23 per share, we believe Freeport-McMoRan stock (NYSE: FCX) is overvalued. FCX stock has rallied from $5 to $23 off its recent bottom compare...
Verisign Stock To Surge To Fresh Highs?
December 1st, 2020 by Trefis Team
Despite a more than 30% rise from its low in March, at the current price of $200 per share, we believe Verisign stock (NASDAQ: VRSN) is still a good opportunity for investors. Verisign stock has risen from $151 to $200 off the recent bottom, le...
Despite A 50% Rally Haemonetics Has More Upside
December 1st, 2020 by Trefis Team
We believe that Haemonetics stock (NYSE: HAE), best known for its blood and plasma supplies and services, is a good buying opportunity at the present time. HAE stock trades near $113 currently and it is, in fact, down 7% from its pre-Covid high ...
ArcelorMittal Stock To Lose Steam After 150% Rally?
December 1st, 2020 by Trefis Team
ArcelorMittal stock (NYSE: MT) has recovered by a formidable 157% since its March lows of 2020. This is much more than the 60% rise in the S&P 500. It is important to note that, the stock has rallied 40% in just the last two months followin...
Moderna Stock Up 2x Last Month, But Still Looks Like Good Value
December 1st, 2020 by Trefis Team
Moderna (NASDAQ: MRNA) published final results from its 30,000-person phase 3 trial of its Covid-19 vaccine and indicated that it would apply for emergency use authorization with the U.S. FDA. The vaccine was over 94% effective in preventing Cov...
Why Does S&P Global Want To Buy IHS Markit?
December 1st, 2020 by Trefis Team
S&P Global (NYSE: SPGI) announced that it would acquire IHS Markit (NYSE: INFO) in a deal that could combine two of the largest financial data providers. The all-stock deal will value IHS Markit at about $44 billion. The deal is likely to ...
Wynn Stock Continues To Defy The Odds
November 30th, 2020 by Trefis Team
The shares of Wynn Resorts (NASDAQ: WYNN) have been on a bull run since the beginning of this month even as the travel and tourism industry came to a grinding halt due to the pandemic. The company took a string of measures in the second quarter t...
Motorola Solutions Stock Can Go Down By 15%
November 30th, 2020 by Trefis Team
Motorola Solutions stock (NYSE: MSI) is up just 8% since the beginning of this year, but at the current price of around $173 per share, we believe that Motorola Solutions stock has 15% potential downside. Why is that? Our belief stems from the...
Down 30% Kohl’s Stock Looks Attractive
November 30th, 2020 by Trefis Team
Kohl’s stock (NYSE: KSS), owner of department stores with apparel, footwear, accessories, and housewares, became vulnerable due to its high operating costs and nonessential product assortment during the pandemic. Consequently, the company&#...
Despite A 65% Rally AbbVie Stock Looks Like It Can Gain More
November 30th, 2020 by Trefis Team
AbbVie stock (NYSE: ABBV) is up 18% since the start of the year and it has gained around 62% from its March lows. Despite the recent rally, AbbVie could offer an upside in the near term, as the company’s revenues in the last three quarters have g...
Does A Quick Digital Transition & Reasonable Valuation Make WW International A Buy?
November 30th, 2020 by Trefis Team
While WW International (formerly known as Weight Watchers International) has seen its stock recover significantly from lows seen in March, it remains down by about 15% year to date. This is in contrast with the broader S&P 500 which is up by ...
Should You Buy Bristol Myers Squibb Stock At $63?
November 30th, 2020 by Trefis Team
We believe that Bristol Myers Squibb stock (NYSE: BMY) is a good buying opportunity at the present time. BMY stock trades near $63 currently and it is, in fact, down 6% from its pre-Covid high of $67 in February 2020 – just before the coronaviru...
Boston Properties Stock Has A 40% Upside
November 30th, 2020 by Trefis Team
We believe that Boston Properties stock (NYSE: BXP) has an upside potential of 42% in 1-1.5 years, once the office spaces fully open and the demand in commercial property lease markets improves to pre-Covid levels. BXP trades at $102 currently...
